8–10% Volume Growth Hinges on June Normalcy

Supreme Petrochem Limited — Q4 & FY26 Earnings Call (FY ended 31 Mar 2026)

1. Overall Tone of Management: Neutral (with pockets of optimism)

• Management highlights improving Q4 margins (“operating EBITDA margins improving to 15.9%”) and commissioning success (“EPS Phase-II… successfully commissioned on April 14, 2026”).
• However, they repeatedly emphasize high uncertainty and inability to quantify impacts from the West Asia disruption and inventory effects (“very difficult… next to impossible at the moment”; “situation is so fluid”).
• Outlook is conditional on normalization (“If normalcy returns by June end… we should be able to do 8% to 10% volume growth”).

2. Key Themes from Management Commentary

• Q4 performance driven by volumes + spreads, despite volatile raw material pricing:
• Q4 revenue up 3% YoY, driven by “higher volumes and better spreads.”
• March saw a sharp styrene monomer jump due to West Asia conflict and Strait of Hormuz disruption.
• FY26 decline largely price-led, not volume-led:
• FY26 revenue down 11% YoY due to “lower average styrene monomer price… lower by around 17%.”
• Volumes grew modestly (~2%), while realizations fell.
• Demand split: OEM healthy, non-OEM softer:
• “Demand from OEM segments remained healthy… while non-OEM… witnessed some softness.”
• Non-OEM softness attributed to high prices, labor availability issues, and gas supply constraints.
• Supply chain disruption management:
• They claim they met domestic demand via inventory in transit + alternate sourcing, but normalization depends on shipping resuming.
• Capex / project progress with operational constraints:
• ABS plant restarted at ~65% of design capacity due to equipment restoration needs.
• EPS Phase-II commissioned (capacity increase from 85k to 115k tons).
• Haryana/PS projects contingent on IOC styrene monomer commissioning clarity.
• Balance sheet strength:
• “Debt-free” and “investable surplus of INR 700 crores.”
• Capex funded via internal accruals.

3. Q&A Analysis

Theme A: Inventory gains/losses & timing (West Asia disruption)

• Core question(s):
• Quantify inventory gains/losses from March price spike; when will inventory losses be booked (Q1/Q2?).
• Whether Q4 profitability includes material mark-to-market (M2M) effects.
• Management response:
• Could not quantify: “very difficult… rather next to impossible at the moment.”
• Loss/gain depends on dynamic pricing and shipments; normalization timing unknown.
• On accounting mechanics: “whatever loss profit comes in, it gets booked in the business… there is nothing such that the inventory gain has to be booked.”
• Assessment (evasive/partial/strong):
• Evasive on quantification (repeated “cannot estimate”).
• Clear on accounting principle (transaction-based recognition), but this doesn’t resolve the magnitude of inventory effects.

Theme B: Demand response to higher prices + contract strategy

• Core question(s):
• Will OEMs sign contracts at higher prices or wait for price drops?
• Is pass-through working without margin hit?
• Management response:
• OEMs are buying, but they are not entering into contracts now due to fluid raw material/freight costs: “not fair to do a contract at this moment.”
• Non-OEM demand is dented due to price sensitivity + operational constraints (labor/gas).
• Pass-through: incremental costs “will get passed on… only except… if prices start dropping, then… inventory loss.”
• Assessment:
• Strong qualitative clarity on contract pause rationale.
• No quantitative margin protection provided.

Theme C: ABS plant operational status, capacity ramp, and Phase-II timeline

• Core question(s):
• Is 65% capacity the new normal? Can it reach 100%?
• Phase-II ABS timeline and whether FY28 remains the target.
• Volume guidance for FY27 including ABS contribution.
• Management response:
• 65% is temporary: “Once the failure gets resolved we will go to 1,00%.”
• Equipment isolated; collaborators provided alternate arrangements to operate at reduced capacity.
• Phase-II ABS: “As of now, yes, we are still aiming that only” (FY28).
• FY27 volume: conditional—“If normalcy returns by June end… 2nd Quarter onwards… 8% to 10% volume growth.”
• Assessment:
• More confident on direction (ramp to higher utilization) but conditional on normalization.
• Phase-II remains “aiming,” not guaranteed.

Theme D: Raw material sourcing mix and pricing parity

• Core question(s):
• Styrene sourcing geography (Gulf vs China vs US) and inventory cycle.
• Import parity for ABS/PS; whether domestic pricing tracks landed imports.
• Management response:
• Inventory cycle: they focus on meeting domestic demand; “customers are being supplied… as and when they require it.”
• Sourcing: “source some from Asia and from China at the moment.”
• Pricing: commodity grades linked to landed imported material; value-added grades have different differentials.
• They claim no PS imports recently; for ABS they cite market info on booked prices (e.g., “booked at $2,300 and $2,400”).
• Assessment:
• Partial transparency: geography is broad, not quantified.
• Pricing parity explained conceptually; no full numeric bridge.

Theme E: Capex plans (FY27) and Haryana/IOC dependency

• Core question(s):
• FY27 capex breakdown; status of Haryana CAPEX; whether PS/EPS spend is delayed.
• Management response:
• Company-wide capex FY27: “around Rs. 250 crores.”
• Haryana PS/EPS: “not committing any expense… once… IOC’s SM plant commissioning date… then only… big monies.”
• EPS Phase-II already commissioned; EPS demand segments discussed later.
• Assessment:
• Clear dependency on IOC; capex discipline narrative.

Theme F: Working capital / cash flow drivers

• Core question(s):
• Why operating cash flow weakened (higher working capital, higher debtors).
• Management response:
• March selling/purchase prices went up; ABS volumes increased; inventory increased—“all that adds to that.”
• Expect normalization back to earlier receivable cycle: “once these things become normal… they will go back.”

4. Guidance / Outlook

Explicit guidance (quantitative)

• Volume growth (FY27):
• “If normalcy returns by June end… 2nd Quarter onwards… we should be able to do 8% to 10% volume growth this year.”
• FY27 volume composition (qualitative/conditional):
• OEM/non-OEM demand: OEM healthy; non-OEM still pressured (no numeric split for FY27).
• Capex (FY27):
• “For the year… around Rs. 250 crores.”
• ABS operational ramp (qualitative with numbers):
• Expect ABS operational utilization to improve to “85%, 90% or 80% of that capacity this year” (wording varies across questions).
• EPS growth / company volume growth:
• Reiterated company-level volume growth expectation: “8% to 10% volume growth this year” (war normalization by June/July).

Implicit signals (qualitative)

• Contracting pause during fluid pricing/freight conditions (suggests near-term margin volatility risk).
• Non-OEM demand remains fragile due to structural constraints (labor/gas) and price sensitivity.
• Export constraints: exports to Europe via longer shipping route (“only thru cape of Good Hope… shipping time increased, freight rates gone up”), implying weaker export contribution until conditions normalize.
• Inventory risk acknowledged: they expect inventory loss “the moment the whole situation normalizes.”

5. Standout Statements (direct / highly revealing)

• On inventory quantification (uncertainty):
• “very difficult… rather next to impossible at the moment” (inventory gain/loss estimate).
• On contract strategy during disruption:
• “we are not entering into contracts at the moment because the situation is so fluid… shipping costs have gone up…”
• On ABS ramp and recovery:
• “Once the failure gets resolved we will go to 1,00%.”
• On EPS expansion success:
• “EPS Phase-II expansion… was successfully commissioned on April 14, 2026… enhancing… from 85,000… to 115,000…”
• On FY27 volume guidance being conditional:
• “If normalcy returns by June end… we should be able to do 8% to 10% volume growth.”
• On inventory accounting mechanics (limits to “M2M” narrative):
• “whatever loss profit comes in, it gets booked in the business… there is nothing such that the inventory gain has to be booked…”

6. Red Flags / Positive Signals

Red flags
– Repeated inability to quantify inventory impacts despite analysts asking directly—creates earnings quality uncertainty.
– Guidance is conditional on geopolitical/shipping normalization by June; downside risk if delays persist.
– Non-OEM demand softness tied to operational constraints (labor/gas) could linger beyond a quarter.
– Export headwinds explicitly mentioned (route/freight time), potentially limiting upside.

Positive signals
– Commissioning milestone achieved (EPS Phase-II) and ABS restart underway.
– Debt-free + internal accrual funding supports execution credibility.
– OEM demand described as healthy; suggests demand base remains intact.
– Management acknowledges inventory loss risk rather than denying it.

7. Historical Comparison & Consistency Analysis (vs prior 3 calls)

a. Change in Tone Over Time

• Earlier calls (Q1 FY26, Q2/H1 FY26, Q3 FY26): tone was more about styrene price stabilization/seasonality and ABS commissioning progress, with fewer geopolitical “inventory timing” uncertainties.
• Current call (Q4 FY26): tone shifts to macro/geopolitical disruption + uncertainty management:
• West Asia conflict, Strait of Hormuz disruption, freight spikes.
• Management is more defensive on quantification (“next to impossible”).
• Classification: More cautious than earlier calls, mainly due to inability to estimate inventory effects and conditional guidance.

b. Tracking Past Commitments vs Outcomes

• ABS commissioning / restart timeline
• Past (Q3 FY26, Jan 2026): ABS commissioned Sept 2025; shutdown in Dec due to critical equipment; restart timing uncertain.
• Now (Apr 2026 call): ABS restarted with modified arrangements at ~65% capacity.
• Status: ✅ Partially delivered (restart achieved, but not at full capacity; ramp still in progress).
• EPS Phase-II
• Past: not clearly highlighted as commissioned in earlier transcripts provided.
• Now: EPS Phase-II commissioned April 14, 2026.
• Status: ✅ Delivered (execution milestone met).
• Haryana/PS capex dependence on IOC styrene monomer
• Past (Q2/H1 FY26, Oct 2025): Panipat/Haryana linked to IOC SM availability; delays discussed.
• Now: “not committing… until… IOC’s SM plant commissioning date” clarity.
• Status: ⏳ Delayed / still pending (dependency remains unresolved).

c. Narrative Shifts

• From “price-driven cyclicality” → “geopolitical logistics-driven uncertainty”:
• Earlier calls focused on monsoon seasonality, destocking, and styrene price movements.
• Current call adds shipping chokepoint disruption and high seas inventory dynamics as central drivers.
• From ABS ramp optimism → ABS operational constraint realism:
• Earlier: ABS commissioning and ramp expectations.
• Current: ABS at 65% with equipment snag; ramp to 80–90% “this year” but still conditional.

d. Consistency & Credibility Signals

• Credibility is mixed (Medium):
• Consistent: debt-free, internal accrual funding, OEM demand resilience, and conditional guidance logic.
• Inconsistent/weak: repeated refusal to quantify inventory gains/losses and timing, even when asked multiple times.
• No clear overpromising on EPS commissioning (now delivered), but ABS ramp remains constrained.

e. Evolution of Key Themes

• Demand: OEM healthy throughout; non-OEM softness becomes more explicit and tied to operational constraints in current call.
• Margins: Q4 margin improvement is highlighted, but management repeatedly warns that normalization could trigger inventory losses.
• Expansion: EPS Phase-II delivered; ABS Phase-II still “aiming FY28.”
• Macro/risk: geopolitical shipping disruption becomes the dominant new risk theme.

f. Additional Insights (cross-period)

• Working capital volatility is becoming more pronounced as ABS inventory/receivables add complexity (explicitly cited in cash flow Q&A).
• Management’s “transaction-based” inventory accounting explanation suggests they may avoid giving investors a clean “inventory gain/loss” bridge—potentially masking earnings quality sensitivity during volatile periods.

Company: Supreme Petrochem Limited
Period: Q4 & Financial Year 2026 (ended 31 Mar 2026)